PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jroyalcgpracBJGP at RCGPBJGP at PubMed CentralJ R Coll Gen Pract at PubMed CentralRCGP homepage
 
J R Coll Gen Pract. 1975 December; 25(161): 863–873.
PMCID: PMC2159845

Revaccination against measles—a pilot study

Abstract

(1) During the first ten years after primary vaccination with live measles virus vaccine, a slow decline in the level of HAI antibody titres has been demonstrated. The decline after more attenuated vaccines was at the same gradient, but at lower titres.

(2) During the same period after primary vaccination by inactivated (` killed ') followed by live — K + L — measles vaccine, a much steeper decline in the level of HAI antibody titres was demonstrated.

(3) The GMT may not reach the lowest standard titres for over 40 years after the least attenuated vaccine, and 20-25 years after more attenuated vaccines. After K + L vaccine the GMT may be negative after 15 years or less, but this will depend on the frequency of natural boosting.

(4) On revaccination after five to ten years, one out of 20 children (five per cent) who had received live vaccine alone for primary vaccination showed a fourfold or greater rise in titre of HAI antibody, whereas 17 out of 41 children (41%) who had received K + L vaccine showed a significant rise in titre.

(5) With either regime, the age at primary vaccination did not appear to influence the rate of boosting after revaccination except perhaps in children under two years.

(6) Among those who originally received K + L Vaccine, The Lower The Hai Antibody Titre Before Revaccination And The Longer The Time Since Primary Vaccination, The More Likely Was A Significant Rise In Titre To Occur After Revaccination. All Should Be Revaccinated Within 10-15 Years Of Primary Immunisation.

(7) Children whose primary vaccination was by live `further attenuated' vaccine before the age of two years may need to be revaccinated before they leave school, but this requires further study.

(8) A case can be made for using a less attenuated strain of measles virus for revaccination than for primary vaccination.

(9) The eventual need for and timing of revaccination against measles should be examined in a larger group of children.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • KRUGMAN S, GILES JP, FRIEDMAN H, STONE S. STUDIES ON IMMUNITY TO MEASLES. J Pediatr. 1965 Mar;66:471–488. [PubMed]
  • Krugman S. Present status of measles and rubella immunization in the United States: a medical progress report. J Pediatr. 1971 Jan;78(1):1–16. [PubMed]
  • Leedham-Green JC. Epidemic measles. Modification by killed virus vaccine, given two years previously. J Coll Gen Pract. 1965 Nov;10(3):244–246. [PMC free article] [PubMed]
  • Linnemann CC, Jr, Dine MS, Bloom JE, Schiff GM. Measles antibody in previously immunized children. The need for revaccination. Am J Dis Child. 1972 Jul;124(1):53–57. [PubMed]
  • Schluederberg A, Lamm SH, Landrigan PJ, Black FL. Measles immunity in children vaccinated before one year of age. Am J Epidemiol. 1973 Jun;97(6):402–409. [PubMed]
  • STOKES J, Jr, REILLY CM, BUYNAK EB, HILLEMAN MR. Immunologic studies of measles. Am J Hyg. 1961 Nov;74:293–303. [PubMed]
  • Ueda S, Toyoshima K, Kurose T. Observation of booster infections of measles in mothers of children with measles. Biken J. 1969 Jun;12(2):127–128. [PubMed]
  • WATSON GI. Protection after exposure to measles by attenuated vaccine without gamma-globulin. Br Med J. 1963 Mar 30;1(5334):860–861. [PMC free article] [PubMed]
  • WATSON GI. STUDIES ON KILLED AND ATTENUATED MEASLES VACCINES IN GENERAL PRACTICE. Br Med J. 1965 Jul 3;2(5452):13–16. [PMC free article] [PubMed]
  • WATSON GI. SEROLOGICAL STUDIES ON SECOND ATTACKS OF MEASLES AND RUBELLA. Lancet. 1965 Jan 9;1(7376):80–81. [PubMed]
  • Watson GI. Which measles vaccine at what age? R Soc Health J. 1967 Sep-Oct;81(5):266–271. [PubMed]
  • Watson GI, Parry JM. Antibody titres and protective efficacy two to four years after vaccination against measles. Mon Bull Minist Health Public Health Lab Serv. 1967 Aug;26:146–153. [PubMed]

Articles from The Journal of the Royal College of General Practitioners are provided here courtesy of Royal College of General Practitioners